Compare Advanced Drainage Systems Inc (WMS) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Advanced Drainage Systems Inc vs Zoetis Inc — how do they compare? Advanced Drainage Systems Inc trades at $125.79 (market cap $9.52B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 3.2× Advanced Drainage Systems Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Advanced Drainage Systems Inc for 43 Days and Zoetis Inc for 70 Days on average.
| WMS | ZTS | |
|---|---|---|
Market Cap | $9.52B | $30.20B |
Volume | 907,564 | 6,175,327 |
Sector | Basic Materials | Health |
52-Week High | $175.38 | $147.53 |
52-Week Low | $125.33 | $69.09 |
Typical Hold Time | 43 Days | 70 Days |
Enterprise Value | $11.12B | $37.76B |
Dividend Yield | 0.63% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Advanced Drainage Systems (WMS) trades at $126.21, up 0.1% on the day, with a bearish technical signal from moving averages despite neutral oscillators. The company reported strong Q2 2026 earnings of $2.49 per share, beating estimates, and maintains solid profitability with a 14% net income margin. Recent news highlights institutional activity and the release of a sustainability report, while analyst consensus leans bullish with a $188.70 price target.
The outlook for WMS is supported by earnings beats and structural growth in water management solutions, but near-term risks include a projected negative cash flow in 2026 and competitive pressures. The stock offers potential upside relative to analyst targets, though investors should weigh execution risks against the company's market position and margin strength.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Advanced Drainage Systems Inc
Advanced Drainage Systems Inc is engaged in designing, manufacturing, and marketing thermoplastic corrugated pipe and related water management products in North and South America, and Europe. The company's operating segment includes Pipe
Read more on WMS →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
